The Quantum AI Series features exclusive interviews of the global innovators shaping the future of quantum computing. In Episode 4 of Season 2, Maëva Ghonda, the founder and chair of the Quantum AI Institute, interviews Dr. Hans Melo, CEO, Menten AI.

Dr. Hans Melo is co-founder and CEO of Menten AI, Inc., a therapeutics company and leader in quantum computing applications in drug discovery. He holds a PhD in Machine Learning and Computational Neuroscience from the University of Toronto.

Menten AI is a drug discovery company focused on designing peptides for conditions with high unmet medical need. We develop computational methods for protein design that leverage machine learning and quantum computing.